- Home
- CAPT vs COCP Comparison
CAPT vs COCP Comparison
Compare CAPT & COCP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CAPT
- COCP
- Stock Information
- Founded
- CAPT 2005
- COCP 2006
- Country
- CAPT South Korea
- COCP United States
- Employees
- CAPT N/A
- COCP N/A
- Industry
- CAPT Blank Checks
- COCP Biotechnology: Pharmaceutical Preparations
- Sector
- CAPT Finance
- COCP Health Care
- Exchange
- CAPT Nasdaq
- COCP Nasdaq
- Market Cap
- CAPT 16.0M
- COCP 15.7M
- IPO Year
- CAPT N/A
- COCP N/A
- Fundamental
- Price
- CAPT $1.54
- COCP $1.80
- Analyst Decision
- CAPT
- COCP Strong Buy
- Analyst Count
- CAPT 0
- COCP 1
- Target Price
- CAPT N/A
- COCP $6.00
- AVG Volume (30 Days)
- CAPT 357.6K
- COCP 21.6K
- Earning Date
- CAPT 01-01-0001
- COCP 08-13-2025
- Dividend Yield
- CAPT N/A
- COCP N/A
- EPS Growth
- CAPT N/A
- COCP N/A
- EPS
- CAPT N/A
- COCP N/A
- Revenue
- CAPT $17,389,944.00
- COCP N/A
- Revenue This Year
- CAPT N/A
- COCP N/A
- Revenue Next Year
- CAPT N/A
- COCP N/A
- P/E Ratio
- CAPT N/A
- COCP N/A
- Revenue Growth
- CAPT 84.70
- COCP N/A
- 52 Week Low
- CAPT $0.37
- COCP $1.12
- 52 Week High
- CAPT $2.88
- COCP $3.26
- Technical
- Relative Strength Index (RSI)
- CAPT 71.95
- COCP 69.71
- Support Level
- CAPT $1.14
- COCP $1.46
- Resistance Level
- CAPT $1.21
- COCP $1.60
- Average True Range (ATR)
- CAPT 0.08
- COCP 0.08
- MACD
- CAPT 0.02
- COCP 0.02
- Stochastic Oscillator
- CAPT 86.54
- COCP 92.31
About CAPT Captivision Inc.
Captivision Inc Formerly Glaam Co Ltd is engaged in manufacturing, installing, and selling LED display G-Glass. G-Glass is an integrated ICT product that has the basic characteristics of transparent glass but can display media images at the same time. It implements media images through the glass surface while preserving the features of clear and transparent glass. G-Glass is the world's first IT building material that can be applied to various places where glass is used.
About COCP Cocrystal Pharma Inc.
Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first and in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).